(Q30990327)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15907738%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

review article

1 reference

title

Clinically isolated syndromes suggestive of multiple sclerosis, part 2: non-conventional MRI, recovery processes, and management (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15907738%20AND%20SRC:MED&resulttype=core&format=json

magnetic resonance imaging

12 January 2020

main subject

multiple sclerosis

0 references

0 references

author

Xavier Montalban

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15907738%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Massimo Filippi

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15907738%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1

David Miller

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15907738%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

2

Frederik Barkhof

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15907738%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

4

Alan Thompson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15907738%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

publication date

1 June 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15907738%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15907738%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15907738%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15907738%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

page(s)

341-348

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15907738%20AND%20SRC:MED&resulttype=core&format=json

Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance

12 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Measurement of spinal cord area in clinically isolated syndromes suggestive of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

A conventional and magnetization transfer MRI study of the cervical cord in patients with MS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Normal-appearing brain tissue MTR histograms in clinically isolated syndromes suggestive of MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

An MT MRI study of the cervical cord in clinically isolated syndromes suggestive of MS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Normal-appearing white matter in optic neuritis and multiple sclerosis: a comparative proton spectroscopy study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Magnetisation transfer ratios and transverse magnetisation decay curves in optic neuritis: correlation with clinical findings and electrophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Irreversible disability and tissue loss in multiple sclerosis: a conventional and magnetization transfer magnetic resonance imaging study of the optic nerves

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Serial magnetization transfer imaging in acute optic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Detection of optic nerve atrophy following a single episode of unilateral optic neuritis by MRI using a fat-saturated short-echo fast FLAIR sequence

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Continuing optic nerve atrophy following optic neuritis: a serial MRI study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

A serial MRI study following optic nerve mean area in acute optic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

1 reference

7 January 2021

Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Optic neuritis: correlation of pain and magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Recovery from optic neuritis is associated with a change in the distribution of cerebral response to visual stimulation: a functional magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Functional MRI of the visual cortex and visual testing in patients with previous optic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Evidence for axonal pathology and adaptive cortical reorganization in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Simple and complex movement-associated functional MRI changes in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Cord damage elicits brain functional reorganization after a single episode of myelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Optic neuritis treatment trial. One-year follow-up results

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Practice parameter: the role of corticosteroids in the management of acute monosymptomatic optic neuritis. Report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Plasma exchange for severe attacks of CNS demyelination: predictors of response

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

The optic neuritis treatment trial: three-year follow-up results

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta1a.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Brain atrophy, interferon beta, and treatment trials in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

New diagnostic criteria for multiple sclerosis: application in first demyelinating episode.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

The value of diagnostic information to patients with suspected multiple sclerosis. Rochester-Toronto MRI Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

[Attitude of patients with multiple sclerosis to illness information]

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Delivering the diagnosis of MS - results of a survey among patients and neurologists

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Neurologic impairment 10 years after optic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Studies on the natural history of multiple sclerosis--8. Early prognostic features of the later course of the illness

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

The natural history of multiple sclerosis: a regional study with some longitudinal data

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970095-8

7 January 2021

10.1016/S1474-4422(05)70095-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15907738%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference